Diagnosis and clinical features of epidermolysis bullosa acquisita

Dermatologic Clinics

Volumn 29, Issue 3, 2011, Pages 485-491

  Caux, Frédéric ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

Anchoring fibrils; Autoimmunity; Blistering disease; Collagen VII; Diagnosis; Epidermolysis bullosa acquisita

Indexed keywords

AUTOANTIBODY; COLLAGEN TYPE 17; RECOMBINANT PROTEIN;

AUTOIMMUNE SKIN DISEASE; BASEMENT MEMBRANE; BLISTER; BULLOUS SKIN DISEASE; CLINICAL FEATURE; CROHN DISEASE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMOLYSIS BULLOSA ACQUISITA; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOBLOTTING; IMMUNOELECTRON MICROSCOPY; IMMUNOPATHOGENESIS; LABORATORY TEST; MUCOSA; PRIORITY JOURNAL; RARE DISEASE; REVIEW; SKIN; SKIN FRAGILITY; SKIN SCAR;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; DIAGNOSIS, DIFFERENTIAL; EPIDERMOLYSIS BULLOSA ACQUISITA; HUMANS; SKIN;

EID: 79956272431     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2011.03.017     Document Type: Review

References (33)

1. Bernard P., Vaillant L., Labeille B., et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. French Bullous Study Group. Arch Dermatol 1995, 131(1):48-52.
2. Bertram F., Bröcker E.B., Zillikens D., et al. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 2009, 7(5):434-440.
3. Woodley D.T., Remington J., Chen M. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita. Clin Rev Allergy Immunol 2007, 33(1-2):78-84.
4. Lapiere J.C., Woodley D.T., Parente M.G., et al. Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 1993, 92(4):1831-1839.
5. Gammon W.R., Murrell D.F., Jenison M.W., et al. Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain. J Invest Dermatol 1993, 100(5):618-622.
6. Tanaka T., Furukawa F., Imamura S. Epitope mapping for epidermolysis bullosa acquisita autoantibody by molecularly cloned cDNA for type VII collagen. J Invest Dermatol 1994, 102(5):706-709.
7. Ishii N., Yoshida M., Ishida-Yamamoto A., et al. Some epidermolysis bullosa acquisita sera react with epitopes within the triple-helical collagenous domain as indicated by immunoelectron microscopy. Br J Dermatol 2009, 160(5):1090-1093.
8. Hill P.B., Boyer P., Lau P., et al. Epidermolysis bullosa acquisita in a great Dane. J Small Anim Pract 2008, 49(2):89-94.
9. Sitaru C., Mihai S., Otto C., et al. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest 2005, 115(4):870-878.
10. Woodley D.T., Ram R., Doostan A., et al. Induction of epidermolysis bullosa acquisita in mice by passive transfert of autoantibodies from patients. J Invest Dermatol 2006, 126(6):1323-1330.
11. Sitaru C., Chiriac M.T., Mihai S., et al. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J Immunol 2006, 177(5):3461-3468.
12. Mihai S., Chiriac M.T., Takahashi K., et al. The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita. J Immunol 2007, 178(10):6514-6521.
13. Abrams M.L., Smidt A., Benjamin L., et al. Congenital epidermolysis bullosa acquisita. Arch Dermatol 2011, 147(3):337-341.
14. Ludwig R., Recke A., Bieber K., et al. Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita antigen. J Invest Dermatol 2011, 131(1):167-176.
15. Alexandre M., Brette M.D., Pascal F., et al. A prospective study of upper aerodigestive tract manifestations of mucous membrane pemphigoid. Medicine 2006, 85(4):239-252.
16. Shipman A.R., Agero A.L., Cook I., et al. Epidermolysis bullosa acquisita requiring multiple oesophageal dilatations. Clin Exp Dermatol 2008, 33(6):787-789.
17. Vodegel R.M., de Jog M.C., Pas H.H., et al. IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. J Am Acad Dermatol 2002, 47(6):919-925.
18. Caux F., Kirtschig G., Lemarchand-Venencie F., et al. IgA-epidermolysis bullosa acquisita in a child resulting in blindness. Br J Dermatol 1997, 137(2):270-275.
19. Cox N.H., Bearn M.A., Herold J., et al. Blindness due to the IgA variant of epidermolysis bullosa acquisita, and treatment with osteo-odonto-keratoprosthesis. Br J Dermatol 2007, 156(4):775-777.
20. Le Roux-Villet C., Prost-Squarcioni C., Heller M., et al. Epidermolysis bullosa acquisita: a clinical, histological and immunological study of 39 cases. Ann Dermatol Venereol 2002, 129. 1S71-1S72.
21. Gammon W.R., Briggaman R.A., Inman A.O., et al. Differentiating anti-lamina lucida and antisublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol 1984, 82(2):139-144.
22. Dainichi T., Kurono S., Ohyama B., et al. Anti-laminin gamma-1 pemphigoid. Proc Natl Acad Sci U S A 2009, 106(8):2800-2805.
23. Grootenboer-Mignot S., Descamps V., Picard-Dahan C., et al. Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatoses. Br J Dermatol 2010, 162(4):743-750.
24. Ishii N., Yoshida M., Hisamatsu Y., et al. Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy. Br J Dermatol 2004, 150(5):843-851.
25. Chen M., Keene D.R., Costa F.K., et al. The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis bullosa acquisita autoantibodies. J Biol Chem 2001, 276(24):21649-21655.
26. Chen M., O'Toole E.A., Sanghavi J., et al. The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with Crohn's disease have autoantibodies to type VII collagen. J Invest Dermatol 2002, 118(6):1059-1064.
27. Müller R., Dahler C., Möbs C., et al. T and B cells target identical regions of the non-collagenous domain 1 of collagen VII in epidermolysis bullosa acquisita. Clin Immunol 2010, 135(1):99-107.
28. Pendaries V., Le Roux C., Vitezica Z.G., et al. Valeur diagnostique et pronostique d'un test Elisa sur un homotrimère recombinant de collagène VII dans l'épidermolyse bulleuse acquise et le lupus érythémateux vésiculobulleux. Ann Dermatol Venereol 2008, 135S:A68-A69.
29. Chan L.S., Majmudar A.A., Tran H.H., et al. Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. J Invest Dermatol 1997, 108(6):848-853.
30. Vaillant L., Bernard P., Joly P., et al. Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. Arch Dermatol 1998, 134(9):1075-1080.
31. Hundorfean G., Neurath M.F., Sitaru C. Autoimmunity against type VII collagen in inflammatory bowel disease. J Cell Mol Med 2010, 14(10):2393-2403.
32. Gammon W.R., Briggaman R.A. Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Dermatol Clin 1993, 11(3):535-547.
33. Vassileva S. Bullous systemic lupus erythematosus. Clin Dermatol 2004, 22(2):129-138.